← Leaderboards
Jiahe Li
Northeastern University
$4,053,585
Attributed
$5,799,631
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,799,631 · 5
By mechanism
R01$3,492,093 · 2
DP2$1,355,273 · 1
R21$611,414 · 1
R03$340,851 · 1
Top collaborators
- Yatrik M Shah1 shared
- Omer Yilmaz1 shared
Others in their field
Other Emerging Leaders on “Bacteria”
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Gary Fanger · Rise Therapeutics, Llc$19,697,313
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$14,299,891
Research focus
BacteriaMicrobeCellsMediatingMicrobialPathogenesisGeneticFutureLinkClustered Regularly Interspaced Short Palindromic RepeatsSuccessIn VivoTechnologyAttentionProteinsOralMouse ModelOverexpressionPublic Health RelevanceCommunitiesComplexKnock-OutIn VitroEnzymes
Grant awards (8)
Understanding and Harnessing Microbial Reprogramming to Combat Carcinogenic Colibactin in Colorectal Cancer$2,864,671
R01 · FY2025 · CA · contact PI
Targeting a human gut bacterial genotoxin via engineered commensal bacteria$627,422
R01 · FY2025 · CA · contact PI
Enzymatic and genetic strategies for targeting disease-associated microbial metabolites$1,355,273
DP2 · FY2023 · GM · contact PI
A New Class of Chemically Modified Small RNA Inhibitors against Fusobacterium nucleatum$167,020
R03 · FY2023 · DE · contact PI
A New Class of Chemically Modified Small RNA Inhibitors against Fusobacterium nucleatum$1
R03 · FY2023 · DE · contact PI
A New Class of Chemically Modified Small RNA Inhibitors against Fusobacterium nucleatum$173,830
R03 · FY2022 · DE · contact PI
Engineering Probiotics to Sense and Respond to the Intracellular Redox Imbalances towards Mitochondrial Dysfunction$581,683
R21 · FY2021 · EB · contact PI
Engineering Probiotics to Sense and Respond to the Intracellular Redox Imbalance towards Mitochondrial Dysfunction$29,731
R21 · FY2021 · EB · contact PI